Urinary fractalkine is a marker of acute rejection

Kidney International

Volumn 74, Issue 11, 2008, Pages 1454-1460

  Peng, Wenhan ^a   Chen, Jianghua ^a,b   Jiang, Yuguang ^a   Wu, Jianyong ^a,b   Shou, Zhangfei ^a,b   He, Qiang ^a   Wang, Yiming ^a   Chen, Ying ^a   Wang, Huiping ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Acute rejection; Fractalkine; Transplantation; Urine

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; FRACTALKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANZYME B; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PERFORIN; PREDNISONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; ADULT; ALLOGRAFT; AREA UNDER THE CURVE; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; URINE LEVEL;

ACUTE DISEASE; ADULT; AREA UNDER CURVE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINE CX3CL1; CHEMOKINES; DRUG RESISTANCE; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; STEROIDS; TRANSPLANTATION, HOMOLOGOUS;

EID: 56549108678     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.459     Document Type: Article

References (33)

1. Hancock WW, Wang L, Ye Q et al. Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression. Curr Opin Immunol 2003; 15: 479-486.
2. Bazan JF, Bacon KB, Hardiman G et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997; 385: 640-644.
3. Imai T, Hieshima K, Haskell C et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997; 91: 521-530.
4. Foussat A, Coulomb-L'Hermine A, Gosling J et al. Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur J Immunol 2000; 30: 87-97.
5. Fong AM, Robinson LA, Steeber DA et al. Fractalkine and CX3CR1 mediates a novel mechanism of leukocyte capture, firm adhesion and activation under physiologic flow. J Exp Med 1998; 188: 1413-1419.
6. Haskell CA, Cleary MD, Charo IF. Unique role of the chemokine domine of fractalkine in cell capture. J Biol Chem 2000; 275: 34183-34189.
7. Colvin RB, Cohen AH, Saiontz C et al. Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol 1997; 8: 1930-1941.
8. Alcalde G, Merino J, Sanz S et al. Circulating adhesion molecules during kidney allograft rejection. Transplantation 1995; 59: 1695-1699.
9. Muller TF, Kraus M, Neumann C et al. Detection of renal allograft rejection by complement components C5A and TCC in plasma and urine. J Lab Clin Med 1997; 129: 62-71.
10. Fogazzi GB, Garigali G. The clinical art and science of urine microscopy. Curr Opin Nephrol Hypertens 2003; 12: 625-632.
11. Thongboonkerd V, Mcleish KR, Arthur JM et al. Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int 2002; 62: 1461-1469.
12. Pieper R, Gatlin CL, McGrath AM et al. Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 2004; 4: 1159-1174.
13. O'Riordan E, Orlova TN, Mei JJ et al. Bioinformatic analysis of the urine proteome of acute allograft rejection. J Am Soc Nephrol 2004; 15: 3240-3248.
14. Voshol H, Brendlen N, Müller D et al. Evaluation of biomarker discovery approaches to detect protein biomarkers of acute renal allograft rejection. J Proteome Res 2005; 4: 1192-1199.
15. Segerer S, Hughes E, Hudkins KL et al. Expression of the fractalkine receptor (CX3CR1) in human kidney diseases. Kidney Int 2002; 62: 488-495.
16. Hauser IA, Spiegler S, Kiss E et al. Prediction of acute renal allograft rejection by urinary monokine induced by IFN-γ (MIG). J Am Soc Nephrol 2005; 16: 1849-1858.
17. Tatapudi RR, Muthukumar T, Dadhania D et al. Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int 2004; 65: 2390-2397.
18. Woltman AM, de Fijter JW, van der Kooij SW et al. MIP-3alpha/CCL20 in renal transplantation and its possible involvement as dendritic cell chemoattractant in allograft rejection. Am J Transplant 2005; 5: 2114-2125.
19. Li B, Hartono C, Ding R et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001; 344: 947-954.
20. Meier-kriesche HU, Schold JD, Srinivas TR et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378-383.
21. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1997; 55: 713-723.
22. Lederer SR, Friedrich N, Regenbogen C et al. Non-invasive monitoring of renal transplant recipients: urinary excretion of soluble adhesion molecules and of the complement-split product C4d. Nephron Clin Pract 2003; 94: 19-26.
23. Hu H, Aizenstein BD, Puchalski A et al. Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction. Am J Transplant 2004; 4: 432-437.
24. Cockwell P, Chakravorty SJ, Girdlestone J et al. Fractalkine expression in human renal inflammation. J Pathol 2002; 196: 85-90.
25. Chen YM, Hu-Tsai MI, Lin SL et al. Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats. Nephrol Dial Transplant 2003; 18: 2505-2514.
26. Chakravorty SJ, Cockwell P, Girdlestone J et al. Fractalkine expression on human renal tubular epithelial cells: potential role in mononuclear cell adhesion. Clin Exp Immunol 2002; 129: 150-159.
27. Yannaraki M, Rebibou J, Ducloux D et al. Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection. Transpl Int 2006; 19: 759-768.
28. Robinson LA, Nataraj C, Thomas DW et al. A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J Immuol 2000; 165: 6067-6072.
29. Haskell CA, Hancock WW, Salant DJ et al. Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection. J Clin Invest 2001; 108: 679-688.
30. Simeoni E, Vassalli G, Seydoux C et al. CCR5, RANTES and CX3CR1 polymorphisms: possible genetic links with acute heart rejection. Transplant 2005; 80: 1309-1316.
31. Wu JY, Chen JH, Wang YM et al. Improved clinical outcomes in Chinese renal allograft recipients receiving lower dose immunosuppressants. Transplant 2004; 78: 713-718.
32. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708-714.
33. Janghua C, Wenqing X, Huiping W et al. C4d as a significant predictor for humoral rejection in renal allografts. Clin Transplant 2005; 19: 785-791.